Imaging of HIV-associated kaposi sarcoma; F-18-FDG-PET/CT and In-111-bevacizumabscintigraphy

Journal of Acquired Immune Deficiency Syndromes

Volumn 54, Issue 4, 2010, Pages 444-446

  Van De Luijtgaarden, Addy ^a   Van Der Ven, Andre ^a   Leenders, William ^a   Kaal, Suzanne ^a   Flucke, Uta ^a   Oyen, Wim ^a   Van Der Graaf, Winette ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUORODEOXYGLUCOSE F 18; INDIUM 111; VASCULOTROPIN A; DIAGNOSTIC AGENT; INDIUM; RADIOISOTOPE;

ADULT; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; DISEASE COURSE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOTOPE LABELING; KAPOSI SARCOMA; LETTER; MALE; PATHOGENESIS; PRIORITY JOURNAL; SCINTIGRAPHY; CANCER OF UNKNOWN PRIMARY SITE; COMPUTER ASSISTED TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SCINTISCANNING;

FLUORODEOXYGLUCOSE F18; HIV INFECTIONS; HUMANS; INDIUM RADIOISOTOPES; NEOPLASMS, UNKNOWN PRIMARY; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES; SARCOMA, KAPOSI; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77955498225     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181cdf61f     Document Type: Letter

References (13)

1. Sullivan R, Dezube BJ, Koon HB. Signal transduction targets in Kaposi's sarcoma. Curr Opin Oncol. 2006;18:456-462.
2. Restrepo CS, Martinez S, Lemos JA, et al. Imaging manifestations of Kaposi sarcoma. Radiographics. 2006;26:1169-1185.
3. Di Lorenzo G, Konstantinopoulos PA, Panta-nowitz L, et al. Management of AIDS-related Kaposi's sarcoma. Lancet Oncol. 2007;8: 167-176.
4. Ferrara N, Hillan KJ, Gerber HP, et al. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov. 2004;3:391-400.
5. Stollman TH, Scheer MG, Leenders WP, et al. Specific imaging of VEGF-A expression with radiolabeled anti-VEGF monoclonal antibody. Int J Cancer. 2008;122:2310-2314.
6. Masood R, Cai J, Zheng T, et al. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci\USA. 1997;94:979-984.
7. Cornali E, Zietz C, Benelli R, et al. Vascular endothelial growth factor regulates angiogen-esis and vascular permeability in Kaposi's sarcoma. Am J Pathol. 1996;149:1851-1869.
8. Vart RJ, Nikitenko LL, Lagos D, et al. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. Cancer Res. 2007; 67:4042-4051.
9. Bonardel G, Coindre JM, Gontier E, et al. Elevated FDG uptake in Kaposi sarcoma mimicking Hodgkin's lymphoma relapse. Clin Nucl Med. 2008;33:624-626.
10. Martinez S, McAdams HP, Youens KE. Kaposi sarcoma after bilateral lung transplantation. J Thorac Imaging. 2008;23:50-53.
11. Lucignani G, Orunesu E, Cesari M, et al. FDG-PET imaging in HIV-infected subjects: relation with therapy and immunovirological variables. Eur J Nucl Med Mol Imaging. 2009; 36:640-647.
12. Scheer MG, Stollman TH, Boerman OC, et al. Imaging liver metastases of colorectal cancer patients with radiolabelled bevacizumab: lack of correlation with VEGF-A expression. Eur J Cancer. 2008;44:1835-1840.
13. Neufeld G, Cohen T, Gengrinovitch S, et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;13:9-22.